'A Turning Point' In The Fight Against Alzheimer's? Biogen Applies For FDA Approval Of Previously-Dropped Drug
Dr. Al Sandrock, chief medical officer at Biogen, spoke with WBUR's All Things Considered host Lisa Mullins about new data that led the biotech giant to submit for approval an Alzh…
